Table 4.

Adjusted Comparison of WASID and SAMMPRIS for the SAMMPRIS Primary Endpoint among SAMMPRIS Medical Patients and SAMMPRIS-Eligible WASID Patients^*

Characteristic	Parameter Estimate	Standard Error	p-value	Hazard Ratio (95% CI)
WASID vs SAMMPRIS	0.64745	0.26861	0.016	1.9 (1.1 – 3.2)
Not Using Statin at Enrollment	0.31519	0.28168	0.26	1.4 (0.8 – 2.4)
Old Infarcts in the Territory	0.66134	0.25311	0.009	1.9 (1.2 – 3.2)

^*The estimates are based on a proportional hazards regression model with 352 patients.